Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 07 01:54PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-19.78 Insider Own0.69% Shs Outstand1.24M Perf Week33.27%
Market Cap16.19M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.23M Perf Month27.41%
Income-15.95M PEG- EPS next Q- Inst Own12.84% Short Float / Ratio1.10% / 1.99 Perf Quarter3.57%
Sales111.12M P/S0.15 EPS this Y- Inst Trans-56.35% Short Interest0.01M Perf Half Y12.20%
Book/sh61.13 P/B0.21 EPS next Y- ROA-4.20% Target Price200.00 Perf Year11.07%
Cash/sh26.88 P/C0.49 EPS next 5Y46.00% ROE-23.68% 52W Range8.98 - 24.20 Perf YTD-14.83%
Dividend- P/FCF- EPS past 5Y35.15% ROI-6.55% 52W High-46.02% Beta1.32
Dividend %- Quick Ratio1.21 Sales past 5Y-24.66% Gross Margin59.49% 52W Low45.47% ATR0.67
Employees122 Current Ratio1.59 Sales Q/Q-17.30% Oper. Margin-29.68% RSI (14)71.26 Volatility7.21% 5.20%
OptionableNo Debt/Eq3.16 EPS Q/Q37.27% Profit Margin-14.35% Rel Volume0.19 Prev Close12.49
ShortableYes LT Debt/Eq3.13 EarningsNov 13 AMC Payout- Avg Volume6.82K Price13.06
Recom1.00 SMA2028.90% SMA5022.15% SMA2000.78% Volume1,025 Change4.56%
Date Action Analyst Rating Change Price Target Change
Jun-17-21Upgrade H.C. Wainwright Neutral → Buy $5 → $10
Aug-14-19Downgrade H.C. Wainwright Buy → Neutral $31 → $6
May-23-19Initiated Wedbush Neutral
Dec-11-18Downgrade Goldman Neutral → Sell
Aug-07-18Reiterated Stifel Hold $15 → $25
Feb-16-18Upgrade Piper Jaffray Neutral → Overweight
Jan-17-18Reiterated H.C. Wainwright Buy $34 → $31
Nov-28-17Resumed Piper Jaffray Neutral $22
Nov-16-17Downgrade Stifel Buy → Hold $26 → $15
Nov-16-17Downgrade Raymond James Mkt Perform → Underperform
Nov-14-23 10:34AM
Nov-13-23 04:07PM
Nov-06-23 04:01PM
12:42PM Loading…
Aug-28-23 12:42PM
Aug-08-23 04:21PM
Aug-02-23 08:00AM
Aug-01-23 08:00AM
Jun-28-23 05:08PM
Jun-26-23 08:23AM
Jun-05-23 09:06AM
Jun-02-23 04:01PM
May-31-23 04:01PM
08:00AM Loading…
May-30-23 08:00AM
May-12-23 05:28AM
May-11-23 04:29PM
May-10-23 07:00AM
May-08-23 07:00AM
May-04-23 09:41AM
Apr-24-23 08:00AM
Apr-03-23 08:00AM
Mar-27-23 08:00AM
Mar-09-23 07:00AM
Mar-07-23 07:00AM
Mar-06-23 03:43PM
Feb-14-23 04:46PM
04:01PM Loading…
Jan-31-23 04:01PM
Jan-05-23 04:20PM
Dec-22-22 08:00AM
Dec-20-22 05:30PM
Dec-05-22 07:01AM
Nov-19-22 08:12AM
Nov-11-22 09:52AM
Nov-04-22 09:25AM
Nov-01-22 04:01PM
Oct-27-22 07:00AM
Oct-25-22 04:01PM
Oct-21-22 07:00AM
Oct-19-22 07:00AM
Oct-18-22 07:00AM
Oct-16-22 04:48PM
Oct-10-22 06:30AM
Sep-08-22 04:01PM
Aug-29-22 07:00AM
Aug-19-22 08:00AM
Aug-04-22 04:01PM
Jul-28-22 04:01PM
Jun-16-22 09:31AM
May-11-22 04:01PM
May-04-22 04:01PM
Mar-09-22 04:01PM
Feb-24-22 05:00PM
Jan-04-22 07:11AM
Jan-03-22 04:01PM
Nov-09-21 04:01PM
Nov-02-21 07:00AM
Sep-09-21 08:01AM
Aug-05-21 05:45PM
Jul-30-21 04:01PM
Jul-27-21 03:02PM
Jul-23-21 07:28AM
Jul-22-21 04:01PM
Jun-18-21 10:46PM
Jun-16-21 07:00AM
May-06-21 05:15PM
Apr-29-21 04:30PM
Apr-27-21 12:00PM
Apr-20-21 09:46AM
Apr-12-21 07:00AM
Apr-01-21 07:51AM
Mar-12-21 10:01AM
Mar-11-21 08:52AM
Mar-10-21 11:30AM
Mar-08-21 11:12PM
Mar-05-21 08:15AM
Mar-04-21 05:45PM
Mar-03-21 12:52PM
Mar-02-21 08:43AM
Feb-26-21 10:10AM
Feb-25-21 07:00AM
Feb-19-21 07:00AM
Feb-11-21 11:12AM
Feb-10-21 10:21AM
Feb-08-21 12:40PM
Feb-04-21 11:48AM
Feb-02-21 03:23PM
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine), and Selincro (nalmefene). The firm's also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa, and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COHEN RONPresident and CEOMar 17Buy0.6510,0006,500149,757Mar 20 04:29 PM
COHEN RONPresident and CEOMar 16Buy0.6010,1566,094139,757Mar 20 04:29 PM